Silence Therapeutics (SLN) Other Working Capital Changes: 2019-2025
Historic Other Working Capital Changes for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -$5.3 million.
- Silence Therapeutics' Other Working Capital Changes fell 679.39% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.9 million, marking a year-over-year decrease of 575.53%. This contributed to the annual value of $457,998 for FY2024, which is 104.44% up from last year.
- Per Silence Therapeutics' latest filing, its Other Working Capital Changes stood at -$5.3 million for Q3 2025, which was down 76.64% from -$3.0 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Other Working Capital Changes peaked at $14.3 million during Q3 2023, and registered a low of -$24.2 million during Q4 2024.
- Its 3-year average for Other Working Capital Changes is $709,443, with a median of $592,000 in 2025.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 206.81% in 2022, then tumbled by 679.39% in 2025.
- Quarterly analysis of 5 years shows Silence Therapeutics' Other Working Capital Changes stood at $7.4 million in 2021, then spiked by 53.61% to $11.4 million in 2022, then fell by 0.81% to $11.3 million in 2023, then tumbled by 313.09% to -$24.2 million in 2024, then crashed by 679.39% to -$5.3 million in 2025.
- Its Other Working Capital Changes stands at -$5.3 million for Q3 2025, versus -$3.0 million for Q2 2025 and $592,000 for Q1 2025.